Journal of Clinical Microbiology, December 1999, p. 4099-4106, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Laboratoire de Virologie,
Received 9 April 1999/Returned for modification 24 June
1999/Accepted 23 August 1999
The aim of the present study was to evaluate the
resistance-associated mutations in 302 human immunodeficiency virus
type 1 (HIV-1)-infected patients receiving combination therapy and monitored in Marseille, France, hospitals from January 1997 to June
1998. In the reverse transcriptase (RT) gene, the most frequent mutations were found at codons 215 (53%), 41 (34%), and 67, 70, 184, and 210 (>20%). One deletion and two insertions in the
3-
4 hairpin loop of the finger subdomain (codon 69) were detected. Interesting associations and/or exclusions of specific mutations were
observed. In 96% of RT genes, a mutation at codon 70 (most frequently,
K70R) was associated with a wild-type genotype at position 210 (P < 10
5). Similarly, a mutation at
codon 210 (most frequently, L210W) was generally associated with
mutations at codons 41 (92%) and 215 (96%) but not at codon 219 (16%) or codon 70 (4%) (P < 10
5). In
the protease gene, the most prevalent mutations were at codons 63 (84%), followed by codons 10, 36, 71, 77, and 93 (ca. 20%). As for
RT, pairwise associations of mutations were observed. Analysis of the
mutation patterns for patients with undetectable HIV-1 loads revealed a
high proportion (65%) of wild-type RT genotypes but only 18%
wild-type protease genotypes. For patients with high viral loads
(>100,000 copies/ml), more than 50% of the RT and protease genes
displayed three or more mutations. The significant correlation between
the level of viremia in plasma and the number of resistance
mutations in the protease (P = 0.007) and RT
(P = 0.00078) genes strengthens the importance of
defining the genotype of the predominant HIV-1 quasispecies before
initiating antiretroviral therapy.
*
Corresponding author. Mailing address: Laboratoire de
Biochimie et Biologie de la Nutrition, ESA-CNRS 6033, Faculté des
Sciences de St Jérôme, 13397 Marseille Cedex 20, France.
Phone: 33 491-288-761. Fax: 33 491-288-4400. E-mail:
JACQUES.FANTINI{at}LBBN.u-3mrs.fr.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|